Lab Tests Discriminate Bacterial from Nonbacterial COPD Exacerbations
By LabMedica International staff writers Posted on 08 Dec 2016 |
Image: The UniCel DxH 800 Coulter Cellular Analysis System (Photo courtesy of Beckman Coulter).
The discrimination of bacterial from nonbacterial acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is difficult, causing antibiotics overuse and bacterial resistance. Sputum cultures are of limited use because results take time.
Acute exacerbation of COPD also known as acute exacerbations of chronic bronchitis (AECB) is a sudden worsening of COPD symptoms such as shortness of breath, quantity and color of phlegm that typically lasts for several days. It may be triggered by an infection with bacteria or viruses or by environmental pollutants.
Scientists at the Franciscus Gasthuis (Rotterdam, The Netherlands) and their colleagues usually evaluate AECOPD using the laboratory parameters of leucocytes concentration and C-reactive protein. They have now evaluated additional tests to discriminate bacterial versus nonbacterial AECOPD: 5-part leukocyte differentiation (hematology analyzer), leukocyte differentiation using flow cytometry (Leukoflow, Cytodiff: Beckman Coulter, Brea, CA, USA), Leuko64 kit, and procalcitonin. Retrospectively, patients were classified as bacterial or nonbacterial AECOPD. Receiver operating characteristic (ROC) analyses tested how the additional tests discriminate these groups.
The team classified 22 AECOPD as bacterial and 23 as nonbacterial. From the additional tests, basophil percentage (Cytodiff) has superior AUC (0.800). At a cutoff resulting in equal to or more than 90% sensitivity, neutrophil/lymphocyte ratio (AUC: 0.755) and CD4-positive T cells (Leukoflow, AUC: 0.747) have the highest specificity (57%). Both neutrophil mean volume and standard deviation measured by the Cell Population Data from a Beckman Coulter DxH800 hematology analyzer had good combined sensitivity and specificity (91% sensitivity, 69% specificity). Addition of leukocyte populations and procalcitonin to CRP in regression models (AUC: 0.907/0.876/0.890) increased specificity compared to CRP alone (71% or 73% versus 39%).
The authors concluded that no additional test has sufficient accuracy on its own to predict bacterial AECOPD. Combining CRP with several parameters from the additional tests may improve this. The study was published in the December 2016 issue of the International Journal of Laboratory Hematology.
Related Links:
Franciscus Gasthuis
Beckman Coulter
Acute exacerbation of COPD also known as acute exacerbations of chronic bronchitis (AECB) is a sudden worsening of COPD symptoms such as shortness of breath, quantity and color of phlegm that typically lasts for several days. It may be triggered by an infection with bacteria or viruses or by environmental pollutants.
Scientists at the Franciscus Gasthuis (Rotterdam, The Netherlands) and their colleagues usually evaluate AECOPD using the laboratory parameters of leucocytes concentration and C-reactive protein. They have now evaluated additional tests to discriminate bacterial versus nonbacterial AECOPD: 5-part leukocyte differentiation (hematology analyzer), leukocyte differentiation using flow cytometry (Leukoflow, Cytodiff: Beckman Coulter, Brea, CA, USA), Leuko64 kit, and procalcitonin. Retrospectively, patients were classified as bacterial or nonbacterial AECOPD. Receiver operating characteristic (ROC) analyses tested how the additional tests discriminate these groups.
The team classified 22 AECOPD as bacterial and 23 as nonbacterial. From the additional tests, basophil percentage (Cytodiff) has superior AUC (0.800). At a cutoff resulting in equal to or more than 90% sensitivity, neutrophil/lymphocyte ratio (AUC: 0.755) and CD4-positive T cells (Leukoflow, AUC: 0.747) have the highest specificity (57%). Both neutrophil mean volume and standard deviation measured by the Cell Population Data from a Beckman Coulter DxH800 hematology analyzer had good combined sensitivity and specificity (91% sensitivity, 69% specificity). Addition of leukocyte populations and procalcitonin to CRP in regression models (AUC: 0.907/0.876/0.890) increased specificity compared to CRP alone (71% or 73% versus 39%).
The authors concluded that no additional test has sufficient accuracy on its own to predict bacterial AECOPD. Combining CRP with several parameters from the additional tests may improve this. The study was published in the December 2016 issue of the International Journal of Laboratory Hematology.
Related Links:
Franciscus Gasthuis
Beckman Coulter
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data